Alcon, Cooper, Medtronic prioritize names at Mizuho By

© Reuters. Alcon, Cooper, Medtronic favorite names in Mizuho

By Sam Boughedda

The company’s top buys include Alcon (NYSE:), Cooper Companies (NYSE:), Mizuho analysts said in a note on medical technology and diagnostics stocks on Thursday. and Medtronic (NYSE:).

Analysts said in a memo sent to clients that they see many of the same themes from this year extending into 2023, including “1) hospital health, 2) recession fears, and 3 ) inflationary.”

On the contrary, they also believe that “the pump feels ready for some headwinds that could drive higher valuations”, such as improved procedural volumes, larger-scale M&A and the return of IPO market.

“We’re rolling out coverage on Alcon (ALC, $85) and Cooper Companies (COO, $375) at Buy with both ratings reflecting benefits for vision proving relatively more mediocre compared to other areas of Medtech in previous recessions coupled with the benefit of recent/ongoing product launches provide favorable headwinds next year,” the analysts added.

“Our favorite large-cap names are ALC, COO and MDT, as we see: 1) rich portfolio balance for recession, 2) new product launches (eg. : RDN, Reduced IOP, MiSight), 3) accessibility to high growth target markets (e.g. glaucoma, TAVR, LAA, robotics), and [4]3) many times of research and development on target in the next 3 years.”


News5h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button